Cited by 172Immune Response and InflammationAtherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14 + Monocytes

Open access

Methe, Heiko, Kim, Jong-Oh, Kofler, Sieglinde, Nabauer, Michael, Weis, Michael·2005·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.0000168410.44722.86

Open this paper in CoChat — free account Open PDF

Abstract

Objective— Anti-inflammatory effects of statins contribute to their clinical benefit. Molecular mechanisms underlying these effects have not been well explored. Because statins attenuate lipopolysaccharide (LPS) responsiveness, we hypothesized that part of the pleiotropic effects are mediated through innate immunity. Methods and Results— Toll-like receptor (TLR) 4 expression and downstream signaling in CD14 + monocytes after incubation with simvastatin and atorvastatin were quantified via flow-cytometry, quantitative RT-PCR, kinase assay, and enzyme-linked immunosorbent assay. Incubation with intermediates/ inhibitors of the mevalonate pathway was used to identify the mode of statin action. Statin incubation resulted in a dose-dependent reduction of TLR4 expression (53±7.6% reduction compared with untreated monocytes; P <0.005), transcript levels (68±6.3%; P <0.002), decreased IRAK phosphorylation (37±8.3%; P <0.05), and LPS-induced IL-6, IL-12, tumor necrosis factor (TNF)-α, and B7-1 expression ( P <0.05). Four weeks of treatment with atorvastatin significantly reduced TLR4 expression on circulating CD14 + monocytes by 36.2±4.2% ( P <0.05). Effects of statins were reversed by mevalonate ( P =0.57). Incubation with specific inhibitors of geranylgeranyltransferase (54±4.3%), farnesyltransferase (57±5.1%), or with clostridium-difficile toxin B (58±6.1%, P <0.01) imitated the statin effects. Whereas wortmannin and LY294002 inhibited the statin effect ( P =0.27), incubation with a specific RhoA kinase inhibitor had no effect ( P =0.57). Conclusions— Statins influence TLR4 expression and signaling via inhibition of protein geranylgeranylation and farnesylation. These observations imply interactions with innate immunity as one pleiotropic mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000168410.44722.86

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Toll-like receptor signalling
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Czopik, A. K., Takeda, K., Akira, S., & Medzhitov, R. M. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,364
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,274
Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines
Zarember, K. A., & Godowski, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.554 · Cited by 1,251
Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.
Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · PubMed · Cited by 847
Expression of Toll-Like Receptors in Human Atherosclerotic Lesions
Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · Circulation · doi:10.1161/circ.105.10.1158 · Cited by 706
Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide
Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., & Arditi, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1609 · Cited by 681
Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL
Xu, X.-O. H., Shah, P. K., Faure, E., Equils, O., Thomas, L. S., Fishbein, M. C., Luthringer, D., Xu, X., Rajavashisth, T. B., Yano, J., et al. (2001) · Circulation · doi:10.1161/hc5001.100631 · Cited by 676

Show all 30 references

Research works printed but not linked: 3

10.1161/atvb.21.11.1712 · DOI
10.1161/circ.104.25.3103 · DOI
10.1161/atvb.21.8.1327 · DOI

Sorted by citations

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
Koushki, K., Shahbaz, S. K., Mashayekhi, K., Sadeghi, M., Zayeri, Z. D., Taba, M. Y., Banach, M., Al-Rasadi, K., Johnston, T. P., & Sahebkar, A. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08791-9 · Cited by 382
Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
Gao, W., Xiong, Y., Li, Q., & Yang, H. Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00508 · Cited by 372
Targeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective
Jialal, I., Kaur, H., & Devaraj, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3092 · Cited by 290
Toll-like Receptors in the Vascular System: Sensing the Dangers Within
Goulopoulou, S., McCarthy, C. G., & Webb, R. C. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010090 · Cited by 267
Mechanisms and management of doxorubicin cardiotoxicity
Shi, Y., Moon, M. S., Dawood, S., McManus, B. M., & Liu, P. P. (2011) · Herz · doi:10.1007/s00059-011-3470-3 · Cited by 217
The role of Toll-like receptors in renal diseases
Gluba-Brzózka, A., Banach, M., Hannam, S., Mikhailidis, D. P., Sakowicz, A., & Rysz, J. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.16 · Cited by 197
Effect of statins on toll-like receptors: a new insight to pleiotropic effects
Bahrami, A., Parsamanesh, N., Atkin, S. L., Banach, M., & Sahebkar, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.014 · Cited by 192
Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases
Leon, C. G., Tory, R., Jia, J. X., Sivak, O., & Wasan, K. M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9571-x · Cited by 176
Monocyte tissue factor–dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin
Owens, A. P., Passam, F. H., Antoniak, S., Marshall, S., McDaniel, A. L., Rudel, L. L., Williams, J., Hubbard, B. K., Dutton, J., Wang, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58969 · Cited by 171
Toll like receptor 4 in atherosclerosis and plaque destabilization
den Dekker, W. K., Cheng, C., Pasterkamp, G., & Duckers, H. J. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.075 · Cited by 173
Expression ofmiR-146a/bis associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin–angiotensin system blockade and statins onmiRNA-146a/band Toll-like receptor 4 levels
Takahashi, Y., Satoh, M., Minami, Y., Tabuchi, T., Itoh, T., & Nakamura, M. (2010) · Clinical Science · doi:10.1042/cs20100003 · Cited by 173
The Biological Role of Inflammation in Atherosclerosis
Wong, B. W., Meredith, A., Lin, D., & McManus, B. M. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.023 · Cited by 168
Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
Funderburg, N., Jiang, Y., Debanne, S. M., Labbato, D. E., Juchnowski, S. M., Ferrari, B., Clagett, B. M., Robinson, J., Lederman, M. M., & McComsey, G. A. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000478 · Cited by 163
High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
Ganesan, A., Crum‐Cianflone, N. F., Higgins, J. M., Qin, J., Rehm, C. A., Metcalf, J. A., Brandt, C., Vita, J., Decker, C. F., Sklar, P. A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq115 · Cited by 156
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo
Niessner, A., Steiner, S., Speidl, W. S., Pleiner, J., Seidinger, D., Maurer, G., Goronzy, J. J., Weyand, C. M., Kopp, C. W., Huber, K., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.022 · Cited by 155
Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
Funderburg, N., Jiang, Y., Debanne, S. M., Storer, N. J., Labbato, D. E., Clagett, B. M., Robinson, J., Lederman, M. M., & McComsey, G. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit748 · Cited by 146
Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis
Wittebole, X., Castanares‐Zapatero, D., & Laterre, P. (2010) · Mediators of Inflammation · doi:10.1155/2010/568396 · Cited by 141
Role of Toll-Like Receptors in Infection and Immunity
Cristofaro, P. A., & Opal, S. M. (2006) · Drugs · doi:10.2165/00003495-200666010-00002 · Cited by 128
Toll-like receptors and diabetes: a therapeutic perspective
Dasu, M. R. K., Ramírez, S. M., & Isseroff, R. R. (2011) · Clinical Science · doi:10.1042/cs20110357 · Cited by 123
Macrophages and Alcohol-Related Liver Inflammation
Ju, C. H. (2015) · Alcohol research · doi:10.35946/arcr.v37.2.09 · Cited by 110
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
Zidar, D. A., Juchnowski, S. M., Ferrari, B., Clagett, B. M., Pilch-Cooper, H. A., Rose, S. M., Rodriguez, B. A., McComsey, G. A., Sieg, S. F., Mehta, N. N., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000566 · Cited by 102
Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction
Mura, V. L., Pasarín, M., Meireles, C. Z. D., Miquel, R., Rodrı́guez-Vilarrupla, A., Hide, D., Gracia‐Sancho, J., García‐Pagán, J. C., Bosch, J., & Abraldeṣ, J. G. (2012) · Hepatology · doi:10.1002/hep.26127 · Cited by 101
Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes
Wyss, C. A., Neidhart, M., Altwegg, L. A., Spanaus, K. S., Yonekawa, K., Wischnewsky, M. B., Corti, R., Kucher, N., Roffi, M., Eberli, F. R., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq084 · Cited by 100
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes
Montecucco, F., Burger, F., Pelli, G., Poku, N. K., Berlier, C., Steffens, S., & Mach, F. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/ken466 · Cited by 96
Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo
Dasu, M. R. K., Riosvelasco, A. C., & Jialal, I. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.010 · Cited by 93
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Brandão, S. C. S., Ramos, J. D. O. X., Dompieri, L. T., Godoi, E. T. A. M., de Figueiredo, J. L., SARINHO, E. S. C., Chelvanambi, S., & Aikawa, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.09.002 · Cited by 93
Update on statin-mediated anti-inflammatory activities in atherosclerosis
Montecucco, F., & Mach, F. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0150-y · Cited by 91
Soluble CD14 Levels, Interleukin 6, and Mortality Among Prevalent Hemodialysis Patients
Raj, D. S., Carrero, J. J., Shah, V. O., Qureshi, A. R., Barany, P. F., Heimbürger, O., Lindholm, B., Ferguson, J., Moseley, P. L., & Stenvinkel, P. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.022 · Cited by 89
Reduction in Mortality Associated with Statin Therapy in Patients with Severe Sepsis
Dobesh, P. P., Klepser, D. G., McGuire, T. R., Morgan, C. W., & Olsen, K. M. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.621 · Cited by 88
The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications
Jialal, I., & Kaur, H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0258-7 · Cited by 86
Toll-like receptors: sensing and reacting to diabetic injury in the kidney
Lin, M., & Tang, S. C. W. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft446 · Cited by 86
Clostridium difficile Infection: An Epidemiology Update
Roo, A. C. D., & Regenbogen, S. E. (2020) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0040-1701229 · Cited by 80
The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease
Spirig, R., Tsui, J. C. S., & Shaw, S. (2012) · Cardiology Research and Practice · doi:10.1155/2012/181394 · Cited by 79
Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
Yuan, X., Deng, Y., Guo, X., Shang, J., Zhu, D., & Liu, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.091 · Cited by 79
Hyperlipidemia, tissue factor, coagulation, and simvastatin
Owens, A. P., Byrnes, J. R., & Mackman, N. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.07.003 · Cited by 78
High Dosage of Simvastatin Reduces TNF-α-Induced Apoptosis of Endothelial Progenitor Cells but Fails to Prevent Apoptosis Induced by IL-1β In Vitro
Henrich, D. M., Seebach, C., Wilhelm, K., & Marzi, İ. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2006.04.011 · Cited by 69
Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
Lin, Y.-T., Verma, A., & Hodgkinson, C. P. (2012) · Current Genomics · doi:10.2174/138920212803759712 · Cited by 68
Dysregulated inflammation as a risk factor for pneumonia in the elderly.
Boyd, A. R., & Orihuela, C. J. (2011) · Europe PMC (PubMed Central) · Cited by 64
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure
Földes, G., von Haehling, S., Okonko, D. O., Jankowska, E. A., Poole-Wilson, P. A., & Anker, S. D. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.12.024 · Cited by 66
Simvastatin inhibits lipopolysaccharide‐induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease
Jin, J., Zhang, X., Lu, Z., Li, Y., Lopes-Virella, M. F., Yu, H. H., Haycraft, C. J., Li, Q., Kirkwood, K. L., & Huang, Y. Q. (2013) · Journal of Periodontal Research · doi:10.1111/jre.12132 · Cited by 60
Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide – Induced cytokine production in monocytes of hypercholesterolemic patients
Moutzouri, E., Tellis, C. C., Rousouli, K., Liberopoulos, E. N., Milionis, H. J., Elisaf, M., & Tselepis, A. D. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.037 · Cited by 62
Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia
Boyd, A. R., Hinojosa, C. A., Rodriguez, P. J., & Orihuela, C. J. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-73 · Cited by 57
Statins in prevention and treatment of severe sepsis and septic shock
Kouroumichakis, I., Παπάνας, Ν., Proikaki, S., Zarogoulidis, P., & Maltezos, E. S. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.12.004 · Cited by 50
Statins and foam cell formation: Impact on LDL oxidation and uptake of oxidized lipoproteins via scavenger receptors
Hofnagel, O., Luechtenborg, B., Weißen-Plenz, G., & Robenek, H. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.06.003 · Cited by 48
Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population
Coen, P. M., Flynn, M. G., Markofski, M. M., Pence, B. D., & Hannemann, R. E. (2010) · Metabolism · doi:10.1016/j.metabol.2010.05.002 · Cited by 47
Statins in the critically ill
Loecker, I. D., & Preiser, J. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-19 · Cited by 45
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Wasiak, S., Dzobo, K. E., Rakai, B. D., Kaiser, Y., Versloot, M., Bahjat, M., Stotz, S. C., Fu, L., Sweeney, M., Johansson, J. O., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00943-0 · Cited by 45
Endotoxemia of Metabolic Syndrome: A Pivotal Mediator of Meta-Inflammation
Jialal, I., & Rajamani, U. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.1504 · Cited by 45
Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment
Kapelouzou, A., Giaglis, S., Peroulis, M., Katsimpoulas, M., Moustardas, P., Aravanis, C. V., Kostakis, A. I., Karayannakos, P. E., & Cokkinos, D. V. (2017) · Journal of Vascular Research · doi:10.1159/000457797 · Cited by 44
Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice
Wu, L. H., Huang, C., Adhikarakunnathu, S., Mateo, L. R. S., Duffy, K. E., Rafferty, P., Bugelski, P. J., Raymond, H. A., Deutsch, H., Picha, K. M., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.04.015 · Cited by 44
Endothelial Lipase is Increased by Inflammation and Promotes LDL Uptake in Macrophages
Yasuda, T., Hirata, K., Ishida, T., Kojima, Y., Tanaka, H., Okada, T., Quertermous, T., & Yokoyama, M. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e502 · Cited by 43
Atorvastatin affects TLR4 clustering via lipid raft modulation
Chansrichavala, P., Chantharaksri, U., Sritara, P., Kosoltanapiwat, N., & Chaiyaroj, S. C. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.04.027 · Cited by 41
Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer
Mishra, V., & Pathak, C. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.142 · Cited by 40
TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients
Shao, L., Zhang, P., Zhang, Y., Lu, Q., & Ma, A. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0421-3 · Cited by 39
Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression
Hodgkinson, C. P., & Ye, S. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283050aff · Cited by 36
Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation
Sundararaj, K. P., Samuvel, D. J., Li, Y., Nareika, A., Slate, E. H., Sanders, J. J., Lopes-Virella, M. F., & Huang, Y. Q. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108064 · Cited by 35
Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes
Khan, S., Huda, B., Bhurka, F., Patnaik, R., & Banerjee, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178429 · Cited by 50
Toll-Like Receptors, Their Ligands, and Atherosclerosis
Hodgkinson, C. P., & Ye, S. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.36 · Cited by 33
Innate Immunity in Sepsis Pathogenesis and Its Modulation: New Immunomodulatory Targets Revealed
Kumar, V., & Sharma, A. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.6.672 · Cited by 33
Can statins reduce the inflammatory response associated with preterm birth in an animal model?
Basraon, S., Menon, R., Makhlouf, M. A., Longo, M., Hankins, G. D. V., Saade, G. R., & Costantine, M. M. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.020 · Cited by 32
Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock
Selejan, S., Poss, J., Walter, F., Hohl, M., Kaiser, R., Kazakov, A., Böhm, M., & Link, A. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr377 · Cited by 32
Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders
Yadav, A., Betts, M. R., & Collman, R. G. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0433-8 · Cited by 31
Association between Toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina
Mizoguchi, E., Orihara, K., Hamasaki, S., Ishida, S., Kataoka, T., Ogawa, M., Saihara, K., Okui, H., Fukudome, T., Shinsato, T., et al. (2006) · Coronary Artery Disease · doi:10.1097/mca.0b013e328010a474 · Cited by 30
Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells
Yang, S. S., Li, R.-G., Qu, X., Fang, W., & Quan, Z. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.09.008 · Cited by 30
Modulatory Effects of Atorvastatin on Endothelial Cell–Derived Chemokines, Cytokines, and Angiogenic Factors
Zineh, I., Luo, X., Welder, G. J., DeBella, A. E., Wessel, T. R., Arant, C. B., Schofield, R. S., & Chegini, N. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.3.333 · Cited by 30
Myeloid cell differentiation in response to calcitriol for expressionCD11bandCD14is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase
Moeenrezakhanlou, A., Shephard, L., Lam, L. L. C., & Reiner, N. E. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1207833 · Cited by 30
Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats
Nozu, T., Miyagishi, S., Kumei, S., Nozu, R., Takakusaki, K., & Okumura, T. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.056 · Cited by 28
Simvastatin Suppresses Lung Inflammatory Response in a Rat Cardiopulmonary Bypass Model
Shao, H., Shen, Y., Liu, H., Dong, G., Qiang, J., & Hua, J. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.022 · Cited by 28
Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair
Markovic‐Plese, S., Singh, A. K., & Singh, I. (2008) · Future Neurology · doi:10.2217/14796708.3.2.153 · Cited by 28
Increased Expression of CD14 in Macrophages after Inhibition of the Cholesterol Biosynthetic Pathway by Lovastatin
Frey, T., & Maio, A. D. (2007) · Molecular Medicine · doi:10.2119/2007-00054.frey · Cited by 28
A Standardized Chemically Modified Curcuma longa Extract Modulates IRAK-MAPK Signaling in Inflammation and Potentiates Cytotoxicity
Rana, M., Maurya, P., Reddy, S. S., Singh, V., Ahmad, H., Dwivedi, A. K., Dikshit, M., & Barthwal, M. K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00223 · Cited by 28
Modulating effects of omega-3 fatty acids and pioglitazone combination on insulin resistance through toll-like receptor 4 in type 2 diabetes mellitus
Eraky, S. M., Abdel‐Rahman, N., & Eissa, L. A. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.06.009 · Cited by 29
Turmerone enriched standardized Curcuma longa extract alleviates LPS induced inflammation and cytokine production by regulating TLR4–IRAK1–ROS–MAPK–NFκB axis
Rana, M., Reddy, S. S., Maurya, P., Singh, V., Chaturvedi, S., Kaur, K., Agarwal, H., Ahmad, H., Naqvi, A., Dwivedi, A. K., et al. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.04.034 · Cited by 29
Mevalonate Biosynthesis Intermediates Are Key Regulators of Innate Immunity in Bovine Endometritis
Healey, G. D., Collier, C., Griffin, S., Schuberth, H., Sandra, O., Smith, D. G., Mahan, S. M., Dieuzy-Labaye, I., & Sheldon, I. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501080 · Cited by 27
The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4
Yang, J., Zhang, X.-D., Yang, J. M., Ding, J., Liu, Z., Li, S.-G., & Yang, R. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-9970-z · Cited by 27
Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
Li, Y.-J., Chen, C., Yang, J., & Chiu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982264 · Cited by 26
Toll-like receptor modulation: A novel therapeutic strategy in cardiovascular disease?
Katsargyris, Α., Klonaris, C. N., Bastounis, E., & Theocharis, S. E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1329 · Cited by 26
Early Statin Use is Associated with Increased Risk of Infection After Stroke
Becker, K. J., Tanzi, P., Kalil, A., Shibata, D. K., & Cain, K. C. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2011.06.008 · Cited by 25
Efficacy of atorvastatin on hippocampal neuronal damage caused by chronic intermittent hypoxia: Involving TLR4 and its downstream signaling pathway
Deng, Y., Yuan, X., Guo, X., Zhu, D., Pan, Y., & Liu, H. (2015) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2015.07.006 · Cited by 25
Toll-Like Receptors
Erickson, B., Sperber, K. E., & Frishman, W. H. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e3181709fd8 · Cited by 25
Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia
Bruserud, Ø., Reikvam, H., & Brenner, A. K. (2022) · Molecules · doi:10.3390/molecules27030735 · Cited by 24
HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients
Lin, H., Xiao, Y., Chen, G., Fu, D., Ye, Y., Liang, L., Fan, J., Yang, X., Sun, L., & Xu, H. (2010) · Rheumatology International · doi:10.1007/s00296-010-1510-6 · Cited by 24
Toll-like receptors as potential therapeutic targets in cardiac dysfunction
Hofmann, U., Ertl, G., & Frantz, S. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.566560 · Cited by 24
Atorvastatin suppresses Toll-like receptor 4 expression and NF-κB activation in rabbit atherosclerotic plaques.
Fang, D., Yang, S. S., Quan, W., Jia, H., Quan, Z., & Qu, Z. (2014) · PubMed · Cited by 24
Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation
Linnenberger, R., Hoppstädter, J., Wrublewsky, S., Ampofo, E., & Kiemer, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212480 · Cited by 23
Probucol Attenuates Inflammation and Increases Stability of Vulnerable Atherosclerotic Plaques in Rabbits
Li, T., Chen, W., An, F., Tian, H., Zhang, J., Peng, J., Zhang, Y., & Guo, Y. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.225.23 · Cited by 23
For whom the disc tolls: intervertebral disc degeneration, back pain and toll-like receptors
Bisson, D. G., Mannarino, M., Racine, R., & Haglund, L. (2021) · European Cells and Materials · doi:10.22203/ecm.v041a23 · Cited by 22
Statins enhance toll‐like receptor 4‐mediated cytokine gene expression in astrocytes: Implication of Rho proteins in negative feedback regulation
Konat, G. W., Krasowska‐Zoladek, A., & Kraszpulski, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21509 · Cited by 23
Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis
Jung, R., Wendeler, M. W., Danevad, M., Himmelbauer, H., & Gessner, R. V. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3470-z · Cited by 21
Effect of Atorvastatin on PM 10 -induced Cytokine Production by Human Alveolar Macrophages and Bronchial Epithelial Cells
Sakamoto, N., Hayashi, S., Mukae, H., Vincent, R., Hogg, J. C., & van Eeden, S. F. (2009) · International Journal of Toxicology · doi:10.1177/1091581809333140 · Cited by 20
Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins
Katsargyris, Α., Klonaris, C. N., Tsiodras, S., Bastounis, E., Giannopoulos, A. G., & Theocharis, S. E. (2011) · Vascular · doi:10.1258/vasc.2011.oa0306 · Cited by 19
HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation
Fildes, J. E., Shaw, S. M., Mitsidou, A., Rogacev, K. S., Leonard, C. T., Williams, S. G., & Yonan, N. A. (2008) · Transplant Immunology · doi:10.1016/j.trim.2008.02.002 · Cited by 19
Statins Fail to Improve Outcome in Experimental Cerebral Malaria and Potentiate Toll-Like Receptor-Mediated Cytokine Production by Murine Macrophages
Helmers, A. J., Gowda, D. C., Kain, K. C., & Liles, W. C. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.09-0204 · Cited by 17
Undertreatment or Overtreatment With Statins: Where Are We?
García-Fernández-Bravo, I., Torres-Do-Rego, A., López-Farré, A. J., Valle, F. G., Rodríguez, P. D., & Alvarez-Sala-Walther, L. A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.808712 · Cited by 19
The effect of statin therapy withdrawal on monocyte subsets
Jaipersad, A. S., Shantsila, E., Blann, A. D., & Lip, G. Y. H. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12183 · Cited by 17
Inflammatory responses to metal oxide ceramic nanopowders
Jamieson, S., Mawdesley, A., Deehan, D. J., Kirby, J. A., Holland, J. P., & Tyson-Capper, A. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-89329-7 · Cited by 16
TLR3 and TLR4 as potential clinical biomarkers for in-stent restenosis in drug-eluting stents patients
Shao, L., Ma, A., Li, J., & Ping, Z. (2015) · Immunologic Research · doi:10.1007/s12026-015-8685-6 · Cited by 16
Leukocyte, plasma, and organ‐associated cytokine profiles in an animal model of acute inflammation
Ebdrup, L., Krog, J., Granfeldt, A., Larsen, P. Ø., Vestergaard, C., Hokland, M., & Tønnesen, E. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.00982.x · Cited by 16

Authors: Methe, H., Kim, J.-O., Kofler, S., Nabauer, M., & Weis, M.
Affiliations: Ludwig-Maximilians-Universität München (DE)
From the Department of Cardiology, Ludwig-Maximilians-University, Munich, Germany.
ORCID: Methe, Heiko
Kim, Jong-Oh
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2005-07
Volume: 25
Issue: 7
Pages: 1439-1445
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.0000168410.44722.86
OpenAlex: W2143835519
Cited by: 172
References: 30
Citations by year: 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 8 · 2020: 8 · 2019: 1 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 11 · 2014: 10 · 2013: 11 · 2012: 18
FWCI: 4.11
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: Pfizer
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: statins, simvastatin, atorvastatin, TLR4, CD14+ monocytes, innate immunity, lipopolysaccharide, mevalonate pathway, geranylgeranylation, farnesylation, geranylgeranyltransferase inhibitors, farnesyltransferase inhibitors, Clostridium difficile toxin B, anti-inflammatory activity, cytokine expression
MeSH terms: Atorvastatin, Phosphoinositide-3 Kinase Inhibitors, Adult, Bacterial Proteins, Bacterial Toxins, Cells, Cultured, Drug Interactions, Female, Heptanoic Acids, Humans, Lipopolysaccharides, Male, Middle Aged, Monocytes, Protein Kinases, Pyrroles, RNA, Messenger, Signal Transduction, Gene Expression, Cytokines, Protein Prenylation, B7-1 Antigen, Lipopolysaccharide Receptors, Hydroxymethylglutaryl-CoA Reductase Inhibitors, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Phosphatidylinositol 3-Kinases, Protein Kinase Inhibitors, Toll-Like Receptor 4, Interleukin-1 Receptor-Associated Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14 + Monocytes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks